conv.

← The whole story
Health
Roche's obesity drug shows 15.5% weight loss in mid-stage diabetes trial

Roche plans late-stage trials for 2027

2 Sep 22 · 1d ago · 2 articles · 1 source · development 2 of 2

Roche announced plans to begin late-stage glycemic-control and cardiovascular outcomes studies in the first half of 2027, advancing enicepatide toward potential approval.

Roche plans late-stage trials for 2027
Investing.com News

“Swiss drugmaker Roche announced Tuesday that its experimental obesity treatment helped patients with type 2 diabetes reduce blood sugar levels and lose an average 15.5% of their body weight in a mid-stage trial.”

Investing.com · rss ↗

Roche Swiss pharmaceutical companyEli LillyEli Lilly Obesity drug market leaderNovo Nordisk Obesity drug market leaderAstraZeneca Competing obesity drug developerAmgen Competing obesity drug developer

The whole story articles the bright band is this development · numbered dots are the others · click one to jump

Peak 2 pieces in one hour at Sep 22, 12 AM; 4 pieces over 2 days (4 articles) Sep 22, 12 AM — 2 pieces · 2 articles — Google News 2Sep 22, 1 AM — quietSep 22, 2 AM — quietSep 22, 3 AM — quietSep 22, 4 AM — quietSep 22, 5 AM — 1 piece · 1 article — Newswires 1Sep 22, 6 AM — 1 piece · 1 article — Newswires 1Sep 22, 7 AM — quietSep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quiet 12
1Roche announces diabetes trial results…2Roche plans late-stage trials for 2027
8 AM4 PMyesterday8 AM4 PMnow · 12:59 AM ET

Reported in the same hours no headline names this development itself — these 1 claim were published in its stretch

  1. 2 outlets Roche GLP-1 delivers 16% weight loss in mid-stage trial

    first by Seeking Alpha, 1d ago · also Investing.com News

    1 more headline

All 2 developments of Roche's obesity drug shows 15.5% weight loss in mid-stage… →

NewswiresGoogle News